|
|
Article: NanoString Announces NCI Has Adopted Its Gene Expression Technology.
- Article from:
- Gene Therapy Weekly
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs. One system was purchased by the NCI Center for Cancer Research (CCR) through the Institute's Office of Science and Technology Partnerships, and a second was purchased by SAIC-Frederick, operations and technical support contractor to NCI-Frederick (see also NanoString Technologies, Inc.).
The nCounter Analysis System provides highly multiplexed, direct digital detection and counting of individual biological molecules in a ...